WRAL Tech Wire

 LabCorp strikes testing services deal with Murdoch Research Institute

The lab testing giant's clinical trials services group will work with the Murdock group at the N.C. Research Campus to develop new diagnostics, biomarker assays.

 LabCorp shares fall 3% despite beating Street estimates

 LabCorp extends $85.4M buyout offer; Barclays Bank picks SAS for expansion; Li-ion Motors secures $2M loan

 LabCorp extends - again - its $85.4M buyout offer for DNA testing firm

 LabCorp extends $85.4M buyout offer for DNA testing firm

 LabCorp to acquire lab firm focusing on clinical trials

Burlington-based Laboratory Corporation of America says it has agreed to buy Canada-based Clearstone Central Laboratories.

 FTC questions delay LabCorp's acquisition of DNA testing firm

The Burlington-based lab testing firm says the Federal Trade Commission has asked for more information about the deal.

 LabCorp, its shares at 52-week high, beats Street's expectations

 Report: LabCorp moving 146 jobs to NC from Massachusetts

According to an internal memo, the lab testing giant is preparing to cut 146 positions from a Genzyme operation that the company acquired. The jobs reportedly will be moved to LabCorp's headquarters in Burlington.

 LabCorp buys DNA testing firm for $85.4M

The Burlington-based lab testing firm plans to pay cash for Orchid Cellmark, which focuses on identity testing services.

 LabCorp 4Q profits beat Street expectations

Annual revenues top $5 billion for the global laboratory testing company.

 LabCorp makes virology testing data available to researchers

The drug testing firm publishes "Virology Report," which it says is "an unprecedented resource" for testing data.

 GSK's top N. American exec headlines CED biotech conference

Dierdre Connelly will be joined by LabCorp, Talecris, venture firm NEA and Holostic executives as keynote presenters.

 LabCorp gets U.S. nod for Genzyme unit acquisition

The Federal Trade Commission has blessed the deal after an antitrust review.

 LabCorp beats Street estimates on profits by 7 cents per share

The Burlington-based testing giant also raises its profit forecast for the year.

 LabCorp to acquire genetic testing unit of Genzyme for $925M

Genzyme is resisting takeover attempt by Sanofi-Aventis. LabCorp, the Burlington-based global testing company, is paying cash for Genzyme Genetic in a bid to broaden reproductive, genetic, oncology and clinical trials capabilities.

 LabCorp launches genetic test for hepatitis C therapy reaction

 LabCorp beats Street estimates for second quarter earnings, ups guidance

The Burlington, N.C.-based lab testing giant bucks tough economy with profit of $1.46 per share. LabCorp also ups its revenue and profit guidance for the year.

 LabCorp opens bio sample repository at N.C. Research Campus

 LabCorp profit barely misses Street’s expectations

The Burlington-based testing giant blames weather for having “a significant impact” on its financials.